Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis.

Bello E, Cohen JV, Mino-Kenudson M, Dougan M.

J Immunother Cancer. 2019 Feb 11;7(1):41. doi: 10.1186/s40425-019-0524-1.

2.

Experimental simulations of volcanic ash resuspension by wind under the effects of atmospheric humidity.

Del Bello E, Taddeucci J, Merrison JP, Alois S, Iversen JJ, Scarlato P.

Sci Rep. 2018 Sep 28;8(1):14509. doi: 10.1038/s41598-018-32807-2.

3.

Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients.

Capasso Palmiero U, Morosi L, Lupi M, Ponzo M, Frapolli R, Zucchetti M, Ubezio P, Morbidelli M, D'Incalci M, Bello E, Moscatelli D.

Macromol Biosci. 2018 Oct;18(10):e1800164. doi: 10.1002/mabi.201800164. Epub 2018 Jul 25.

PMID:
30047229
4.

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients.

Bello E, Kerry J, Singh S, Yip BH, Kušec R, Killick S, Raynaud S, Boultwood J, Pellagatti A.

Haematologica. 2018 Nov;103(11):e496-e500. doi: 10.3324/haematol.2018.190447. Epub 2018 Jun 14. No abstract available.

5.

Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses.

Wetzel KS, Yi Y, Yadav A, Bauer AM, Bello EA, Romero DC, Bibollet-Ruche F, Hahn BH, Paiardini M, Silvestri G, Peeters M, Collman RG.

PLoS Pathog. 2018 Apr 16;14(4):e1007003. doi: 10.1371/journal.ppat.1007003. eCollection 2018 Apr.

6.

Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin.

Capasso Palmiero U, Morosi L, Bello E, Ponzo M, Frapolli R, Matteo C, Ferrari M, Zucchetti M, Minoli L, De Maglie M, Romanelli P, Morbidelli M, D'Incalci M, Moscatelli D.

J Control Release. 2018 Apr 28;276:140-149. doi: 10.1016/j.jconrel.2018.03.005. Epub 2018 Mar 7.

PMID:
29524443
7.

Deep brain stimulation induces sparse distributions of locally modulated neuronal activity.

Xiao Y, Agnesi F, Bello EM, Zhang S, Vitek JL, Johnson MD.

Sci Rep. 2018 Feb 1;8(1):2062. doi: 10.1038/s41598-018-20428-8.

8.

An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.

Bailey MR, Goldman O, Bello EP, Chohan MO, Jeong N, Winiger V, Chun E, Schipani E, Kalmbach A, Cheer JF, Balsam PD, Simpson EH.

J Neurosci. 2018 Feb 28;38(9):2149-2162. doi: 10.1523/JNEUROSCI.2088-17.2018. Epub 2018 Jan 24.

9.

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.

Belgiovine C, Bello E, Liguori M, Craparotta I, Mannarino L, Paracchini L, Beltrame L, Marchini S, Galmarini CM, Mantovani A, Frapolli R, Allavena P, D'Incalci M.

Br J Cancer. 2017 Aug 22;117(5):628-638. doi: 10.1038/bjc.2017.205. Epub 2017 Jul 6.

10.

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.

Campaner E, Rustighi A, Zannini A, Cristiani A, Piazza S, Ciani Y, Kalid O, Golan G, Baloglu E, Shacham S, Valsasina B, Cucchi U, Pippione AC, Lolli ML, Giabbai B, Storici P, Carloni P, Rossetti G, Benvenuti F, Bello E, D'Incalci M, Cappuzzello E, Rosato A, Del Sal G.

Nat Commun. 2017 Jun 9;8:15772. doi: 10.1038/ncomms15772.

11.

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.

Stacchiotti S, Saponara M, Frapolli R, Tortoreto M, Cominetti D, Provenzano S, Negri T, Dagrada GP, Gronchi A, Colombo C, Vincenzi B, Badalamenti G, Zuco V, Renne SL, Collini P, Morosi C, Dei Tos AP, Bello E, Pilotti S, Casali PG, D'Incalci M, Zaffaroni N.

Eur J Cancer. 2017 May;76:84-92. doi: 10.1016/j.ejca.2017.02.002. Epub 2017 Mar 8.

PMID:
28284173
12.

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.

Romano M, Della Porta MG, Gallì A, Panini N, Licandro SA, Bello E, Craparotta I, Rosti V, Bonetti E, Tancredi R, Rossi M, Mannarino L, Marchini S, Porcu L, Galmarini CM, Zambelli A, Zecca M, Locatelli F, Cazzola M, Biondi A, Rambaldi A, Allavena P, Erba E, D'Incalci M.

Br J Cancer. 2017 Jan;116(3):335-343. doi: 10.1038/bjc.2016.424. Epub 2017 Jan 10.

13.

Effect of particle volume fraction on the settling velocity of volcanic ash particles: insights from joint experimental and numerical simulations.

Del Bello E, Taddeucci J, De' Michieli Vitturi M, Scarlato P, Andronico D, Scollo S, Kueppers U, Ricci T.

Sci Rep. 2017 Jan 3;7:39620. doi: 10.1038/srep39620.

14.

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.

Guffanti F, Chilà R, Bello E, Zucchetti M, Zangarini M, Ceriani L, Ferrari M, Lupi M, Jacquet-Bescond A, Burbridge MF, Pierrat MJ, Damia G.

Neoplasia. 2017 Jan;19(1):35-42. doi: 10.1016/j.neo.2016.11.008. Epub 2016 Dec 15.

15.

Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.

Vázquez R, Licandro SA, Astorgues-Xerri L, Lettera E, Panini N, Romano M, Erba E, Ubezio P, Bello E, Libener R, Orecchia S, Grosso F, Riveiro ME, Cvitkovic E, Bekradda M, D'Incalci M, Frapolli R.

Int J Cancer. 2017 Jan 1;140(1):197-207. doi: 10.1002/ijc.30412. Epub 2016 Sep 19.

16.

Inducible ablation of dopamine D2 receptors in adult mice impairs locomotion, motor skill learning and leads to severe parkinsonism.

Bello EP, Casas-Cordero R, Galiñanes GL, Casey E, Belluscio MA, Rodríguez V, Noaín D, Murer MG, Rubinstein M.

Mol Psychiatry. 2017 Apr;22(4):595-604. doi: 10.1038/mp.2016.105. Epub 2016 Jul 19.

PMID:
27431292
17.

Epidemiological, clinical and prognostic profile of childhood acute bacterial meningitis in a resource poor setting.

Kuti BP, Bello EO, Jegede TO, Olubosede O.

J Neurosci Rural Pract. 2015 Oct-Dec;6(4):549-57. doi: 10.4103/0976-3147.165424.

18.

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

Valletta S, Dolatshad H, Bartenstein M, Yip BH, Bello E, Gordon S, Yu Y, Shaw J, Roy S, Scifo L, Schuh A, Pellagatti A, Fulga TA, Verma A, Boultwood J.

Oncotarget. 2015 Dec 29;6(42):44061-71. doi: 10.18632/oncotarget.6392.

19.

PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers.

Colombo C, Morosi L, Bello E, Ferrari R, Licandro SA, Lupi M, Ubezio P, Morbidelli M, Zucchetti M, D'Incalci M, Moscatelli D, Frapolli R.

Mol Pharm. 2016 Jan 4;13(1):40-6. doi: 10.1021/acs.molpharmaceut.5b00383. Epub 2015 Dec 11.

PMID:
26623665
20.

Symbolism and ritual practices related to hunting in Maya communities from central Quintana Roo, Mexico.

Santos-Fita D, Naranjo EJ, Estrada EI, Mariaca R, Bello E.

J Ethnobiol Ethnomed. 2015 Sep 29;11:71. doi: 10.1186/s13002-015-0055-x.

21.

Promotores As Advocates for Community Improvement: Experiences of the Western States REACH Su Comunidad Consortium.

Kutcher R, Moore-Monroy M, Bello E, Doyle S, Ibarra J, Kunz S, Munoz R, Patton-Lopez M, Sharkey JR, Wilger S, Alfero C.

J Ambul Care Manage. 2015 Oct-Dec;38(4):321-32. doi: 10.1097/JAC.0000000000000073.

PMID:
26353024
22.

Red wine intake but not other alcoholic beverages increases total antioxidant capacity and improves pro-inflammatory profile after an oral fat diet in healthy volunteers.

Torres A, Cachofeiro V, Millán J, Lahera V, Nieto ML, Martín R, Bello E, Alvarez-Sala LA.

Rev Clin Esp. 2015 Dec;215(9):486-94. doi: 10.1016/j.rce.2015.07.002. Epub 2015 Aug 18. English, Spanish.

PMID:
26297333
23.

HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model.

Ceriani L, Ferrari M, Zangarini M, Licandro SA, Bello E, Frapolli R, Falcetta F, D'Incalci M, Libener R, Grosso F, Aviles P, Zucchetti M.

Bioanalysis. 2015;7(15):1831-42. doi: 10.4155/bio.15.117.

PMID:
26295985
24.

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

Bello E, Pellagatti A, Shaw J, Mecucci C, Kušec R, Killick S, Giagounidis A, Raynaud S, Calasanz MJ, Fenaux P, Boultwood J.

Br J Haematol. 2015 Oct;171(2):210-214. doi: 10.1111/bjh.13563. Epub 2015 Jun 18.

25.

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

Pinessi D, Ostano P, Borsotti P, Bello E, Guffanti F, Bizzaro F, Frapolli R, Bani MR, Chiorino G, Taraboletti G, Resovi A.

Connect Tissue Res. 2015;56(5):355-63. doi: 10.3109/03008207.2015.1045065. Epub 2015 Jun 15.

PMID:
25943461
26.

Modulations in oscillatory frequency and coupling in globus pallidus with increasing parkinsonian severity.

Connolly AT, Jensen AL, Bello EM, Netoff TI, Baker KB, Johnson MD, Vitek JL.

J Neurosci. 2015 Apr 15;35(15):6231-40. doi: 10.1523/JNEUROSCI.4137-14.2015.

27.

High Pressure Treatment in Foods.

Bello EF, Martínez GG, Ceberio BF, Rodrigo D, López AM.

Foods. 2014 Aug 19;3(3):476-490. doi: 10.3390/foods3030476. Review.

28.

A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.

Lupi M, Colombo C, Frapolli R, Ferrari R, Sitia L, Dragoni L, Bello E, Licandro SA, Falcetta F, Ubezio P, Bigini P, Salmona M, D'Incalci M, Morbidelli M, Moscatelli D.

Nanotechnology. 2014 Aug 22;25(33):335706. doi: 10.1088/0957-4484/25/33/335706. Epub 2014 Jul 30.

PMID:
25074670
29.

HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies.

Zangarini M, Ceriani L, Bello E, Damia G, Cereda R, Camboni MG, Zucchetti M.

J Mass Spectrom. 2014 Jan;49(1):19-26. doi: 10.1002/jms.3305.

PMID:
24446259
30.

Mode of action of trabectedin in myxoid liposarcomas.

Di Giandomenico S, Frapolli R, Bello E, Uboldi S, Licandro SA, Marchini S, Beltrame L, Brich S, Mauro V, Tamborini E, Pilotti S, Casali PG, Grosso F, Sanfilippo R, Gronchi A, Mantovani R, Gatta R, Galmarini CM, Sousa-Faro JM, D'Incalci M.

Oncogene. 2014 Oct 30;33(44):5201-10. doi: 10.1038/onc.2013.462. Epub 2013 Nov 11.

PMID:
24213580
31.

Prevalence and predictors of compliance with discontinuation of airborne isolation in patients with suspected pulmonary tuberculosis.

Thomas BS, Bello EF, Seto TB.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):967-72. doi: 10.1086/671732. Epub 2013 Jul 25.

32.

Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).

Romano M, Frapolli R, Zangarini M, Bello E, Porcu L, Galmarini CM, García-Fernández LF, Cuevas C, Allavena P, Erba E, D'Incalci M.

Int J Cancer. 2013 Nov;133(9):2024-33. doi: 10.1002/ijc.28213. Epub 2013 May 25.

33.

Central dopamine D2 receptors regulate growth-hormone-dependent body growth and pheromone signaling to conspecific males.

Noaín D, Pérez-Millán MI, Bello EP, Luque GM, Casas Cordero R, Gelman DM, Peper M, Tornadu IG, Low MJ, Becú-Villalobos D, Rubinstein M.

J Neurosci. 2013 Mar 27;33(13):5834-42. doi: 10.1523/JNEUROSCI.5673-12.2013.

34.

The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.

Bello E, Taraboletti G, Colella G, Zucchetti M, Forestieri D, Licandro SA, Berndt A, Richter P, D'Incalci M, Cavalletti E, Giavazzi R, Camboni G, Damia G.

Mol Cancer Ther. 2013 Feb;12(2):131-40. doi: 10.1158/1535-7163.MCT-12-0275-T. Epub 2012 Dec 27.

35.
36.

Diabetic foot ulcerations: biomechanics, charcot foot, and total contact cast.

Malhotra S, Bello E, Kominsky S.

Semin Vasc Surg. 2012 Jun;25(2):66-9. doi: 10.1053/j.semvascsurg.2012.05.001. Review.

PMID:
22817854
37.

Phase II trial of syncopated thalidomide, lenalidomide, and weekly dexamethasone in patients with newly diagnosed multiple myeloma.

Tufail M, Siegel DS, McBride L, Bilotti E, Bello E, Anand P, Olivo K, Bendarz U, McNeill A, Vesole DH.

Clin Lymphoma Myeloma Leuk. 2012 Jun;12(3):186-90. doi: 10.1016/j.clml.2012.01.004. Epub 2012 Feb 28.

PMID:
22381702
38.

Traditional or centralized models of diabetes care: the multidisciplinary diabetes team approach.

Bratcher CR, Bello E.

J Fam Pract. 2011 Nov;60(11 Suppl):S6-11.

PMID:
22336928
39.

Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo.

Sulaiman GM, Ad'hiah AH, Al-Sammarrae KW, Bagnati R, Frapolli R, Bello E, Uboldi S, Romano M, Panini N, Scanziani E, Pezzolato M, Erba E, D'Incalci M.

Food Chem Toxicol. 2012 May;50(5):1632-41. doi: 10.1016/j.fct.2012.01.022. Epub 2012 Jan 28.

PMID:
22306915
40.

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasília, Brazil During 2002-2008.

Bello EJ, Correia AF, Marins JR, Merchan-Hamann E, Kanzaki LI.

Drug Target Insights. 2011;5:33-41. doi: 10.4137/DTI.S7527. Epub 2011 Nov 24.

41.

A report on the first case of vancomycin-intermediate Staphylococcus aureus (VISA) in Hawai'i.

Chaiwongkarjohn S, Pramyothin P, Suwantarat N, Bankowski MJ, Koyamatsu T, Seifried SE, Bello EF.

Hawaii Med J. 2011 Nov;70(11):233-6.

42.

Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors.

Bello EP, Mateo Y, Gelman DM, Noaín D, Shin JH, Low MJ, Alvarez VA, Lovinger DM, Rubinstein M.

Nat Neurosci. 2011 Jul 10;14(8):1033-8. doi: 10.1038/nn.2862.

43.

Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials.

Sulaiman GM, Al Sammarrae KW, Ad'hiah AH, Zucchetti M, Frapolli R, Bello E, Erba E, D'Incalci M, Bagnati R.

Food Chem Toxicol. 2011 Sep;49(9):2415-21. doi: 10.1016/j.fct.2011.06.060. Epub 2011 Jun 24.

PMID:
21723909
44.

E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models.

Bello E, Colella G, Scarlato V, Oliva P, Berndt A, Valbusa G, Serra SC, D'Incalci M, Cavalletti E, Giavazzi R, Damia G, Camboni G.

Cancer Res. 2011 Feb 15;71(4):1396-405. doi: 10.1158/0008-5472.CAN-10-2700. Epub 2011 Jan 6.

45.

Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors.

Frapolli R, Tamborini E, Virdis E, Bello E, Tarantino E, Marchini S, Grosso F, Sanfilippo R, Gronchi A, Tercero JC, Peloso G, Casali P, Pilotti S, D'Incalci M.

Clin Cancer Res. 2010 Oct 15;16(20):4958-67. doi: 10.1158/1078-0432.CCR-10-0317. Epub 2010 Aug 20.

46.

Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.

Frapolli R, Zucchetti M, Sessa C, Marsoni S, Viganò L, Locatelli A, Rulli E, Compagnoni A, Bello E, Pisano C, Carminati P, D'Incalci M.

Eur J Cancer. 2010 Feb;46(3):505-16. doi: 10.1016/j.ejca.2009.11.006. Epub 2009 Dec 16.

PMID:
20007015
47.

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Cervellini I, Bello E, Frapolli R, Porretta-Serapiglia C, Oggioni N, Canta A, Lombardi R, Camozzi F, Roglio I, Melcangi RC, D'incalci M, Lauria G, Ghezzi P, Cavaletti G, Bianchi R.

Neurotox Res. 2010 Aug;18(2):151-60. doi: 10.1007/s12640-009-9127-9. Epub 2009 Oct 30.

PMID:
19876698
48.

Streptococcus pneumoniae: a study of strains isolated from cerebrospinal fluid.

Vieira AC, Gomes MC, Rolo Filho M, Eudes Filho J, Bello EJ, de Figueiredo RB.

J Pediatr (Rio J). 2007 Jan-Feb;83(1):71-8. doi: 10.2223/JPED.1580. Epub 2007 Jan 23.

49.

Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ring.

Beretta GL, Petrangolini G, De Cesare M, Pratesi G, Perego P, Tinelli S, Tortoreto M, Zucchetti M, Frapolli R, Bello E, Manzotti C, Fontana G, Bombardelli E, Battaglia A, Samorì C, Zunino F.

Cancer Res. 2006 Nov 15;66(22):10976-82.

50.

Mycobacterium avium complex olecranon bursitis in a patient treated with alefacept.

Prasertsuntarasai T, Bello EF.

Mayo Clin Proc. 2005 Nov;80(11):1532-3. No abstract available.

PMID:
16295036

Supplemental Content

Support Center